Mechanism of epinephrine's glycogenolytic effect in isolated canine hepatocytes

Epinephrine (10 −7 mol/L) addition to isolated canine hepatocytes activates glycogen phosphorylase from 12.3 ± 0.4 to 28.6 ± 2.6 U/g and glucose output from 42 ± 3 to 170 ± 24 nmol/mg/h. Preincubation of hepatocytes with propranolol (2 × 10 −5 mol/L) caused a 73% inhibition of phosphorylase activati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 1985-11, Vol.34 (11), p.1020-1023
Hauptverfasser: Steiner, Kurt E., Stevenson, Ralph W., Green, Donald R., Cherrington, Alan D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Epinephrine (10 −7 mol/L) addition to isolated canine hepatocytes activates glycogen phosphorylase from 12.3 ± 0.4 to 28.6 ± 2.6 U/g and glucose output from 42 ± 3 to 170 ± 24 nmol/mg/h. Preincubation of hepatocytes with propranolol (2 × 10 −5 mol/L) caused a 73% inhibition of phosphorylase activation and a 77% inhibition of the stimulation of glucose output by epinephrine. Phentolamine (2 × 10 −5 mol/L) on the other hand, caused a 16% inhibition of phosphorylase activation and a 27% inhibition of the stimulation of glucose output by epinephrine. These results were unaffected by the sex of the animal. In the dog the glycogenolytic effects of epinephrine appear to be mediated primarily by a β-adrenergic mechanism.
ISSN:0026-0495
1532-8600
DOI:10.1016/0026-0495(85)90073-3